Science and Clinical Practice
Latency and Reactivation of Human Cytomegalovirus

https://doi.org/10.1053/jinf.2001.0948Get rights and content

Abstract

The sequence analysis of herpesviruses suggests they have been evolving with their individual vertebrate hosts for millions of years, and their divergence parallels that of the hosts they infect. Given this time they have been learning to live with their individual hosts, it is not surprising that they have become extremely well adapted to doing so without causing much in the way of obvious disease. A key feature of their strategy for persisting in the host is the ability of all herpesviruses to establish latent infection—a state in which no, or only a very limited set of, viral genes are expressed in cells in which viral DNA persists. The alpha herpesviruses (herpes simplex and varicella zoster virus) establish latency in neuronal cells in sensory ganglia: these are long lived non-dividing cells and the alpha herpesviruses persist in these with expression of only the latency associated transcripts—although the function of these RNA transcripts remains incompletely understood. The principal gamma herpesvirus of humans, Epstein Barr virus (EBV), is latent mainly in B lymphocytes: EBV persistence in B cells is associated with expression of a limited set of viral genes encoding functions necessary for the maintenance of the episomal viral DNA as B cells divide.

The mechanism by which the principal beta herpesvirus of humans—human cytomegalovirus (HCMV) persists, is also incompletely understood and the subject of this review. Understanding how HCMV persists has clinical relevance in that its transmission to seronegative recipients might be more easily prevented, and the mechanisms by which it produces disease in the neonate and immunocompromised hosts more easily understood, if we knew more about the cells in which the virus is latent and the way in which it reactivates.

References (38)

  • G Hahn et al.

    Cytomegalovirus remains latent in a common precursor of dendritic and myeloid cells

    Proc Natl Acad Sci U.S.A.

    (1998)
  • K Kondo et al.

    Human cytomegalovirus latent infection of granulocyte-macrophage progenitors

    Proc Natl Acad Sci U.S.A.

    (1994)
  • J Taylor-Wiedeman et al.

    Induction of endogenous human cytomegalovirus gene expression after differentiation of monocytes from healthy carriers

    J Virol

    (1994)
  • C Soderberg-Naucler

    Reactivation of latent human cytomegalovirus in CD14(+) monocytes is differentiation dependent

    J Virol

    (2001)
  • KL White et al.

    Human cytomegalovirus latency-associated protein pORF94 is dispensable for productive and latent infection

    J Virol

    (2000)
  • J Taylor-Wiedeman

    Polymorphonuclear cells are not sites of persistence of human cytomegalovirus in healthy individuals

    J Gen Virol

    (1993)
  • C Sinzger

    Tissue macrophages are infected by human cytomegalovirus

    in vivo. J Infect Dis

    (1996)
  • A Grefte

    Circulating cytomegalovirus (CMV)-infected endothelial cells in patients with an active CMV infection

    J Infect Dis

    (1993)
  • C Sinzger

    Modification of human cytomegalovirus tropism through propagation in vitro is associated with changes in the viral genome

    J Gen Virol

    (1999)
  • Cited by (88)

    • CRISPR based genome editing and removal of human viruses

      2021, Progress in Molecular Biology and Translational Science
      Citation Excerpt :

      The virus is able to reactivate from dormancy to start lytic (active, acute, productive) infection to produce tremendous amount of virus progeny in hosts and thereby cause hosts' illness. Two types of viral latency are described as follows8–12: (1) Proviral latency: A provirus is a viral genome which integrates into the host genome, for example, Retrovirus family, such as human immunodeficiency virus (HIV). In this type, viral DNA replicates synchronously with the host genome instead of lysing the host cell and viruses reside in their hosts for long-term. (

    • Significant IFNγ responses of CD8+ T cells in CMV-seropositive individuals with autoimmune arthritis

      2016, Journal of Clinical Virology
      Citation Excerpt :

      Cytomegalovirus (CMV) is a human lymphotropic beta-herpes virus usually causing asymptomatic infection in immunocompetent hosts. Latent CMV infection carries the risk of reactivation in patients with insufficient T-cell immune responses due to immunodeficiency or pharmacological immunosuppression [1]. CMV is controlled by the generation of CMV-specific T-cells to the immunodominant proteins, immediate-early protein IE-1 and the phosphoprotein 65 (pp65) [2,3].

    • Structural basis for clonal diversity of the public T cell response to a dominant human cytomegalovirus epitope

      2015, Journal of Biological Chemistry
      Citation Excerpt :

      root mean square difference. Although CMV infections are usually kept in check by the immune system of immunocompetent individuals, they can cause life-threatening diseases in immunocompromised patients and are a major health concern in patients undergoing bone marrow transplantation (1, 2). In addition, congenital CMV infection is the most common cause of infectious complications in newborns, resulting in deafness and other developmental abnormalities (3).

    • Maintenance and replication of the human cytomegalovirus genome during latency

      2014, Cell Host and Microbe
      Citation Excerpt :

      Human cytomegalovirus (HCMV) can cause significant disease and mortality in immune-compromised individuals. It is well established and accepted that HCMV latent infection occurs primarily in CD34 (+) hematopoietic progenitor cells (HPCs) or CD14 (+) monocytes (Goodrum et al., 2002; Maciejewski et al., 1992; Mendelson et al., 1996; Reeves et al., 2005; Sinclair and Sissons, 1996; Sissons et al., 2002; Söderberg-Nauclér et al., 1997; Taylor-Wiedeman et al., 1991; Zhuravskaya et al., 1997). Although latency has been studied in a variety of natural and experimental systems, the mechanisms involved in HCMV genome maintenance are poorly understood.

    View all citing articles on Scopus
    f1

    Please address all correspondence to: Professor J. G. P. Sissons, University of Cambridge School of Clinical Medicine, Department of Medicine, Level 5, Addenbrooke's Hospital, Hills Road, Cambridge CB2 2QQ, UK.

    View full text